ROBINS LAUNCHING REFORMULATED DIMETAPP OTC ON JUNE 3, COMPANY ANNOUNCES AT ITS ANNUAL MEETING; LATEST IN-LICENSE IS BAYER ANTIHYPERTENSIVE MUZOLAMINE